Success Metrics

Clinical Success Rate
62.5%

Based on 5 completed trials

Completion Rate
63%(5/8)
Active Trials
0(0%)
Results Posted
160%(8 trials)
Terminated
3(30%)

Phase Distribution

Ph phase_3
2
20%
Ph phase_1
7
70%
Ph phase_2
1
10%

Phase Distribution

7

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
7(70.0%)
Phase 2Efficacy & side effects
1(10.0%)
Phase 3Large-scale testing
2(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

5 of 10 finished

Non-Completion Rate

50.0%

5 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(5)
Terminated(5)

Detailed Status

Completed5
Terminated3
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
62.5%
Most Advanced
Phase 3

Trials by Phase

Phase 17 (70.0%)
Phase 21 (10.0%)
Phase 32 (20.0%)

Trials by Status

withdrawn220%
terminated330%
completed550%

Recent Activity

0 active trials
Showing 5 of 10
terminatedphase_3

A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia

NCT02783573
terminatedphase_2

An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease

NCT02245737
terminatedphase_3

A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia

NCT02972658
completedphase_1

A Drug Interaction Study of Lanabecestat (LY3314814) and Warfarin in Healthy Participants

NCT02540668
completedphase_1

A Drug-Drug Interaction Study of Lanabecestat (LY3314814) in Healthy Participants

NCT02406261
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT02783573Phase 3

A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia

Terminated
NCT02245737Phase 2

An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease

Terminated
NCT02972658Phase 3

A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia

Terminated
NCT02540668Phase 1

A Drug Interaction Study of Lanabecestat (LY3314814) and Warfarin in Healthy Participants

Completed
NCT02406261Phase 1

A Drug-Drug Interaction Study of Lanabecestat (LY3314814) in Healthy Participants

Completed
NCT03019549Phase 1

A Study of Lanabecestat (LY3314814) in Healthy Participants When Taken With Rosuvastatin

Completed
NCT02663128Phase 1

A Study of Lanabecestat (LY3314814) in Healthy Participants

Completed
NCT02568397Phase 1

A Drug-drug Interaction Study of Lanabecestat (LY3314814) in Healthy Participants

Completed
NCT03545087Phase 1

A Study of Lanabecestat in Participants With Severe Kidney Impairment Compared to Healthy Participants

Withdrawn
NCT03506399Phase 1

A Study of Lanabecestat in Healthy Female Participants Taking Oral Contraceptive

Withdrawn

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10